Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
77,692,158
-
Share change
-
-2,311,622
-
Total reported value
-
$56,141,000
-
Price per share
-
$0.72
-
Number of holders
-
61
-
Value change
-
-$4,225,730
-
Number of buys
-
19
-
Number of sells
-
42
Institutional Holders of AVALO THERAPEUTICS INC - COM (AVTX) as of Q1 2022
As of 31 Mar 2022,
AVALO THERAPEUTICS INC - COM (AVTX) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,692,158 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Nantahala Capital Management, LLC, Point72 Asset Management, L.P., BlackRock Inc., VANGUARD GROUP INC, Opaleye Management Inc., GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, STATE STREET CORP, and Ikarian Capital, LLC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.